The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Cellular carboxypeptidases
Abstract
Summary: This article focuses on four human carboxypeptidases (CPs): two metallo‐CPs and two serine CPs. The metallo‐CPs are members of the so‐called B‐type regulatory CP family, as they cleave only the C‐terminal basic amino acids Arg or Lys. The plasma membrane‐bound CPM and the mainly, but not exclusively, intracellular CPD are surveyed from this group of enzymes. These enzymes can regulate pep tide hormone activity at the cell surface and possibly intracellularly after receptor‐mediated endocytosis and may also participate in peptide hormone processing. The serine CPs, as their name indicates, contain a serine residue in the active center essential for catalytic activity that reacts with organophosphorus inhibitors, Prolylcarboxypeptidase (PRCP) (angiotensinase C) and deamidase (cathepsin A, lysosomal protective protein) are discussed here. These two enzymes are highly concentrated in lysosomes: however, they may also be active extracellularly after their release from lysosomes in soluble form or in a plasma membrane‐bound complex. Whereas deamidase cleaves a variety of peptides with C‐terminal or penultimate hydrophobic residues (e.g. substance P, angiotensin I, bradykinin, endothelin, fMet‐Leu‐Phe), PRCP cleaves only peptides with a penultimate Pro residue (e.g. des‐Arg°‐bradykinin, angiotensin II). These enzymes may also be involved in terminating signal transduction by inactivating peptide ligands after receptor endocytosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beside CTSA has role in inactivation of bioactive peptides including bradykinin, substances P, oxytocin, angiotensin I and endothelin-I by cleavage of 1 or 2 amino acid(s) from C-terminal ends.”
From Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides (2016) · cites this paper as Skidgel and Erdös, 1998
In the citing paper
“Several in vitro studies showed that CTSA is involved in activation or inactivation of these peptides by removing last one or two amino acid residues (Skidgel and Erdös, 1998).”
From Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides (2016) · cites this paper as Skidgel and Erdös, 1998
Citations
Cites
Caspases: Intracellular Signaling by Proteolysis
Salvesen, G. S., & Dixit, V. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80430-4 · Cited by 2,117
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
Chartrain, N. A., Geller, D. A., Koty, P. P., Sitrin, N. F., Nussler, A. K., Hoffman, E. P., Billiar, T. R., Hutchinson, N. I., & Mudgett, J. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37441-0 · Cited by 394
Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.
D'Azzo, A., Hoogeveen, A., Reuser, A. J., Robinson, D., & Galjaard, H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4535 · Cited by 365
An enzyme in human blood plasma that inactivates bradykinin and kallidins
Erdös, E. G., & Sloane, E. M. (1962) · Biochemical Pharmacology · doi:10.1016/0006-2952(62)90119-3 · Cited by 305
Self-citationRenin???angiotensin system: a dual tissue and hormonal system for cardiovascular control
Johnston, C. I. (1992) · Journal of Hypertension · doi:10.1097/00004872-199212000-00002 · Cited by 275
Li, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.394 · Cited by 245
Bradykinin stimulates tumor necrosis factor and interleukin‐1 release from macrophages
Tiffany, C. W., & Burch, R. M. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81331-6 · Cited by 233
Zinc Metalloproteases In Health And Disease
(1996) · CRC Press eBooks · doi:10.1201/9781482272765 · Cited by 221
Galjart, N. J., Gillemans, N., Harris, A., van der Horst, G. T. J., Verheijen, F. W., Galjaard, H., & d'Azzo, A. (1988) · Cell · doi:10.1016/s0092-8674(88)90999-3 · Cited by 220
Research works printed but not linked: 11
- Folk JE, 1958, Carboxypeptidase B.I. Purification of the zymogen and specificity of the enzyme, J Biol Chem, 231, 379
- Skidgel RA, 1991, Carboxypeptidase (CP) M and H in small intestine, FASEBJ, 5, 1578
- Kas K, 1995, Physical map location of the human carboxypeptidase M gene (CPM) distal to D12S37S and proximal toD12S8 at chromosome 12q15, Genomics, 30, 403
- Skidgel RA, 1993, The Renin Angiotensin System, 101
- URL=http://inhouse.ncbi.nlm.nih.gov/cgi‐bin/UniGene/clust?ORG=Hs&CID=75693.
- Skidgel RA., 1991, Methods in Neurosciences: Peptide Technology, 373
- http://inhouse.ncbi.nlm.nih.gov/cgi‐bin/UniGene/clust?ORG‐Hs&CID=985.
- DeBlois D, 1988, Marceau E Effect of glueocorticoids, monokines and growth factors on the responses of the isolated rabbit aorta to des‐Arg9‐bradykinin (BK), FASEBJ, 2, 1145
- MacFadden RG, 1988, Bradykinin stimulates lymphocyte movement iii vitro, FASEBJ, 2, 1179
- 10.1016/0008-6363(95)00088-7 · doi:10.1016/0008-6363(95)00088-7
- Deddish PA, N‐domain specific substrate and C‐domain inhibitors of angiotensin converting enzyme: Angiotensin‐(1‐7) and keto‐ACE, Hypertension
Cited by
Marshall, R. P., Webb, S., Bellingan, G. J., Montgomery, H. E., Chaudhari, B., McAnulty, R. J., Humphries, S. E., Hill, M. R., & Laurent, G. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108086 · Cited by 412
Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides
Timur, Z. K., Akyildiz Demir, S., & Seyrantepe, V. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00068 · Cited by 38
Metadata
- Authors
- Skidgel, R. A., & Erdös, E. G.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 1998-02
- Volume
- 161
- Issue
- 1
- Pages
- 129-141
- ISSN
- 0105-2896
- 1600-065X
- Cited by
- 155
- References
- 79
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cellular carboxypeptidases. https://app.cochat.ai/papers/10.1111/j.1600-065x.1998.tb01577.x
- The paper
- Skidgel, R. A., & Erdös, E. G. (1998). Cellular carboxypeptidases. Immunological Reviews. https://doi.org/10.1111/j.1600-065x.1998.tb01577.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.